Correlation Between Edwards Lifesciences and BrainsWay

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and BrainsWay at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and BrainsWay into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences Corp and BrainsWay, you can compare the effects of market volatilities on Edwards Lifesciences and BrainsWay and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of BrainsWay. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and BrainsWay.

Diversification Opportunities for Edwards Lifesciences and BrainsWay

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Edwards and BrainsWay is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and BrainsWay in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrainsWay and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with BrainsWay. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrainsWay has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and BrainsWay go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and BrainsWay

Allowing for the 90-day total investment horizon Edwards Lifesciences is expected to generate 27.83 times less return on investment than BrainsWay. But when comparing it to its historical volatility, Edwards Lifesciences Corp is 4.81 times less risky than BrainsWay. It trades about 0.01 of its potential returns per unit of risk. BrainsWay is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  90.00  in BrainsWay on September 26, 2024 and sell it today you would earn a total of  763.00  from holding BrainsWay or generate 847.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Edwards Lifesciences Corp  vs.  BrainsWay

 Performance 
       Timeline  
Edwards Lifesciences Corp 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Edwards Lifesciences showed solid returns over the last few months and may actually be approaching a breakup point.
BrainsWay 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BrainsWay are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, BrainsWay reported solid returns over the last few months and may actually be approaching a breakup point.

Edwards Lifesciences and BrainsWay Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and BrainsWay

The main advantage of trading using opposite Edwards Lifesciences and BrainsWay positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, BrainsWay can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrainsWay will offset losses from the drop in BrainsWay's long position.
The idea behind Edwards Lifesciences Corp and BrainsWay pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world